[Mycoses and antifungals: What is the situation in Senegal in the current context?]

K Diongue; M Ndiaye; M C Seck; M A Diallo; A S Badiane; D Ndiaye

doi:10.1016/j.pharma.2020.11.004

[Mycoses and antifungals: What is the situation in Senegal in the current context?]

Ann Pharm Fr. 2021 Jul;79(4):440-445. doi: 10.1016/j.pharma.2020.11.004. Epub 2020 Nov 21.

[Article in French]

Authors

K Diongue¹, M Ndiaye², M C Seck², M A Diallo³, A S Badiane², D Ndiaye²

Affiliations

¹ Service de parasitologie-mycologie, faculté de medicine, de pharmacie et d'odontologie, université Cheikh Anta Diop, BP 3005, Dakar, Sénégal; Laboratory de parasitologie et mycologie, hôpital Aristide Le Dantec, BP 3001, Dakar, Sénégal. Electronic address: [email protected].
² Service de parasitologie-mycologie, faculté de medicine, de pharmacie et d'odontologie, université Cheikh Anta Diop, BP 3005, Dakar, Sénégal; Laboratory de parasitologie et mycologie, hôpital Aristide Le Dantec, BP 3001, Dakar, Sénégal.
³ Laboratory de parasitologie et mycologie, hôpital Aristide Le Dantec, BP 3001, Dakar, Sénégal.

PMID: 33232707
DOI: 10.1016/j.pharma.2020.11.004

Abstract

In the context of increasing incidence of fungal infections worldwide, the availability of antifungal drugs was studied in Senegal, a country with limited resources where diagnosis of invasive fungal infections is not often established by lack of specialists and/or diagnostic tools. After a background on the country's situation with regard to fungal infections and the drug distribution network in Senegal, a compilation of the various available antifungals was presented before concluding with recommendations to prepare for a situation that could allow to treat appropriately invasive mycoses.

Keywords: Antifongiques; Antifungals; Essential drugs; Mycoses; Médicaments essentiels; Senegal; Sénégal.

MeSH terms

Antifungal Agents* / therapeutic use
Humans
Mycoses* / drug therapy
Mycoses* / epidemiology
Senegal / epidemiology

Substances

Antifungal Agents